Four pharma companies — Glenmark, Lupin, Orchid Chemical and
Pharmaceutical and Aurobindo Pharma — said they have received US Food
and Drug Administration (FDA) approval for marketing levetiracctam
tablets used in the treatment of seizures associated with Epilepsy.
They have got the approval of FDA for marketing and distributing these
tablets in US in 250 mg, 500 mg, 750 mg and 1000 mg strengths, these
companies said in a statement. Levetiracctam tablets are the generic
equivalents of UCB Pharmaceuticals' Keppra tablets and the total annual
market for such tablets is approximately $1.2 billion in US alone.
As Indians we know India in itself is an amazing nation and even the world agrees with that, however, grass is always greener on the other side and that is why Indians desire to immigrate a More
Helplinelaw can set up your session with quality and experienced lawyers to discuss and resolve your legal matters. You can avail consultation in form of sending questions, phone call or webchat discussion More